← All compounds

Glow50

GHK-Cu + TB-500 + BPC-157 · 50mg total · copper blend
A$ 329Rp 3.700.000
Bulk buy pricing
3–5 vials
A$ 298
Save ~9%
6–9 vials
A$ 285
Save ~13%
10+ vials
A$ 258
Save ~22%

A blend of 35mg GHK-Cu, 10mg TB-500, and 5mg BPC-157 in a single vial. Weighted toward GHK-Cu for skin regeneration and firmness, with TB-500 and BPC-157 supporting tissue repair across the body.

Compound overview

What it is

Glow50 combines three complementary mechanisms: GHK-Cu (35mg) drives collagen and elastin synthesis and activates skin regeneration gene programmes. TB-500 (10mg) supports systemic tissue repair and cellular migration. BPC-157 (5mg) promotes angiogenesis, connective tissue healing, and gut mucosal repair. The blend is weighted toward the skin goal — GHK-Cu is the primary active — with TB-500 and BPC-157 providing healing support for the broader tissue environment.

Skin regeneration is the primary visible outcome — tone, firmness, texture, and fine line reduction over a 6–10 week cycle. Simultaneously, connective tissue throughout the body undergoes repair supported by TB-500 and BPC-157. One vial covers a full skin-forward recovery cycle without requiring three separate reconstitutions.

Studied outcomes
  • GHK-Cu: collagen synthesis, gene expression, wound healing (see GHK-Cu pages)
  • TB-500: cellular migration, systemic tissue repair (see TB-500 page)
  • BPC-157: connective tissue and gut repair (see BPC-157 page)
  • Combination approach addresses skin, connective tissue, and vascular healing simultaneously
Suitability

Who it's for

  • Skin-forward protocols with whole-body tissue repair support
  • Clients who want the simplicity of a single-vial cycle
  • Post-injury or post-surgical recovery where skin and tissue healing are both goals
  • Anti-ageing skin protocols with systemic connective tissue support
Who should avoid it
  • Active malignancy — angiogenic components present
  • Known copper sensitivity or Wilson disease
  • Pregnancy
  • Clients who need individual dose control over each component
Dosing guidance

Protocol guidance

Dose
Discuss with your practitioner based on primary goal weight (skin vs. recovery)
Frequency
Typically 3–5 × per week
Cycle length
6–10 weeks
Route
Subcutaneous injection
Timing
No strict timing
Safety

Contraindications & cautions

  • Contains copper (GHK-Cu component) — confirm no copper sensitivity
  • Angiogenic activity (TB-500, BPC-157) — caution in cancer history
  • Dose per component is fixed in the blend — individual titration requires separate vials
Stacking

Pairs well with

Cellular energy and mitochondrial repair alongside skin and tissue regeneration

Immune regulation supports the healing environment

Antioxidant support for skin brightening and cellular protection

Evidence base

Research

See individual compound pages — GHK-Cu, TB-500, BPC-157 ↗

Not medical advice. Not a substitute for medical care. Consult your licensed practitioner before beginning any protocol. Peptides are sold for research purposes only and are suitable for adults aged 18 years and over.